127 related articles for article (PubMed ID: 26606442)
1. Early in vivo discrimination of vulnerable atherosclerotic plaques that disrupt: A serial MRI study.
Pham TA; Hua N; Phinikaridou A; Killiany R; Hamilton J
Atherosclerosis; 2016 Jan; 244():101-7. PubMed ID: 26606442
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging features of vulnerable plaques in an atherosclerotic rabbit model.
Zhao XC; Zhao QM; Ma XH; Zeng CH; Feng TT; Zhao X; Zhang ZQ; Zhang MD; Zhuang XC
Chin Med J (Engl); 2013; 126(11):2163-7. PubMed ID: 23769577
[TBL] [Abstract][Full Text] [Related]
3. In vivo detection of vulnerable atherosclerotic plaque by MRI in a rabbit model.
Phinikaridou A; Ruberg FL; Hallock KJ; Qiao Y; Hua N; Viereck J; Hamilton JA
Circ Cardiovasc Imaging; 2010 May; 3(3):323-32. PubMed ID: 20194634
[TBL] [Abstract][Full Text] [Related]
4. Regions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: an in vivo magnetic resonance imaging study.
Phinikaridou A; Hua N; Pham T; Hamilton JA
Circ Cardiovasc Imaging; 2013 Mar; 6(2):302-10. PubMed ID: 23357244
[TBL] [Abstract][Full Text] [Related]
5. [Predictors of vulnerable atherosclerotic plaques induced by cholesterol and balloon injury in rabbits].
Yin Y; Li Y; Ji XP; Zhang Y; Chen WQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):343-7. PubMed ID: 21624311
[TBL] [Abstract][Full Text] [Related]
6. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
[TBL] [Abstract][Full Text] [Related]
7. Vascular remodeling and plaque vulnerability in a rabbit model of atherosclerosis: comparison of delayed-enhancement MR imaging with an elastin-specific contrast agent and unenhanced black-blood MR imaging.
Phinikaridou A; Andia ME; Indermuehle A; Onthank DC; Cesati RR; Smith A; Robinson SP; Saha P; Botnar RM
Radiology; 2014 May; 271(2):390-9. PubMed ID: 24475852
[TBL] [Abstract][Full Text] [Related]
8. Identification of High-Risk Plaques by MRI and Fluorescence Imaging in a Rabbit Model of Atherothrombosis.
Hua N; Baik F; Pham T; Phinikaridou A; Giordano N; Friedman B; Whitney M; Nguyen QT; Tsien RY; Hamilton JA
PLoS One; 2015; 10(10):e0139833. PubMed ID: 26448434
[TBL] [Abstract][Full Text] [Related]
9. Detection of atherosclerotic plaque progression in the abdominal aorta of rabbits with 3T magnetic resonance imaging.
Ma XH; Zhao L; Zhao QM; Feng TT; Shang JF; Zhang ZQ
Chin Med J (Engl); 2012 Aug; 125(15):2714-8. PubMed ID: 22931980
[TBL] [Abstract][Full Text] [Related]
10. Spatio-temporal texture (SpTeT) for distinguishing vulnerable from stable atherosclerotic plaque on dynamic contrast enhancement (DCE) MRI in a rabbit model.
Wan T; Madabhushi A; Phinikaridou A; Hamilton JA; Hua N; Pham T; Danagoulian J; Kleiman R; Buckler AJ
Med Phys; 2014 Apr; 41(4):042303. PubMed ID: 24694153
[TBL] [Abstract][Full Text] [Related]
11. Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.
Phinikaridou A; Andia ME; Lavin B; Smith A; Saha P; Botnar RM
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940955
[TBL] [Abstract][Full Text] [Related]
12. Characterization of lipid-rich aortic plaques by intravascular photoacoustic tomography: ex vivo and in vivo validation in a rabbit atherosclerosis model with histologic correlation.
Zhang J; Yang S; Ji X; Zhou Q; Xing D
J Am Coll Cardiol; 2014 Jul; 64(4):385-90. PubMed ID: 25060374
[TBL] [Abstract][Full Text] [Related]
13. MRI of atherosclerosis and fatty liver disease in cholesterol fed rabbits.
Taylor E; Huang N; Bodde J; Ellison A; Killiany R; Bachschmid MM; Hamilton J
J Transl Med; 2018 Aug; 16(1):215. PubMed ID: 30068362
[TBL] [Abstract][Full Text] [Related]
14. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
Abela GS; Picon PD; Friedl SE; Gebara OC; Miyamoto A; Federman M; Tofler GH; Muller JE
Circulation; 1995 Feb; 91(3):776-84. PubMed ID: 7828306
[TBL] [Abstract][Full Text] [Related]
15. In vivo MR imaging of plaque disruption and thrombus formation in an atherosclerotic rabbit model.
Ma X; Zhao Q; Zhao L; Shang J; Feng T; Zeng C; Zhang Z
Int J Cardiovasc Imaging; 2012 Mar; 28(3):577-86. PubMed ID: 21461662
[TBL] [Abstract][Full Text] [Related]
16. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
17. Detection of Vulnerable Atherosclerotic Plaques in Experimental Atherosclerosis with the USPIO-Enhanced MRI.
Qi CM; Du L; Wu WH; Li DY; Hao J; Gong L; Deng L; Zhang T; Zhang C; Zhang Y
Cell Biochem Biophys; 2015 Nov; 73(2):331-337. PubMed ID: 27352319
[TBL] [Abstract][Full Text] [Related]
18. MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits.
Kaneko C; Nitta N; Tsuchiya K; Watanabe S; Nitta-Seko A; Ohta S; Otani H; Sonoda A; Murata K; Shiomi M
Br J Radiol; 2015 Sep; 88(1053):20150167. PubMed ID: 26083261
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
20. Antiatherosclerotic effects of the novel angiotensin receptor antagonist Fimasartan on plaque progression and stability in a rabbit model: a double-blind placebo-controlled trial.
Lee JY; Lee CW; Kim WJ; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Son WC; Jung S; Park SW; Park SJ
J Cardiovasc Pharmacol; 2013 Aug; 62(2):229-36. PubMed ID: 23615162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
